lenacapavir Stories
Lenacapavir is administered as a six-monthly injection, starting with a subcutaneous initiation dose, supported by tablets on days one and two.
In 2024, 20,105 adults were newly infected with HIV - a sharp rise from 3,353 cases recorded in 2023. Infections among children also surged from 606 t...
The cheaper version is expected to reach 120 low- and middle-income countries from 2027, pending regulatory approval.
Lenacapavir, an HIV-prevention injection offering six months of protection, will be available from January 2026 at a cost of approximately Sh6,000 per...
The injectable drug, approved by the US Food and Drug Administration in June 2025 and added to updated World Health Organisatio guidelines in July 202...
The drug, lenacapavir, is administered via an injection twice a year.
